Open study of ciprofloxacin in enteric fever

Journal of Antimicrobial Chemotherapy

Volumn 23, Issue 5, 1989, Pages 789-791

  Stanley, P J ^a   Flegg, P J ^b   Mandal, B K ^b   Geddes, A M ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b Monsall Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

ANTIBIOTIC SENSITIVITY; CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TYPHOID FEVER;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CIPROFLOXACIN; FECES; FEMALE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; PARATYPHOID FEVER;

EID: 0024373527     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/23.5.789     Document Type: Article

References (10)

1. Ball, A. P„ Farrell, I. D., Gillen, A. P„ Geddes, A. M., Clarke, P. D. and Ellis, C. J. (1979). Enteric fever in Birmingham: clinical features, laboratory investigation and comparison of treatment with pivmedllinam and co-trimoxazole. Journal of Infection 1, 353-65.
2. Brogard, J.-M., Jehl, F., Monteil, H., Adlofif, M., BKckle, J.-F. and Levy, P. (1985). Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Antimicrobial Agents and Chemotherapy 28, 311-4.
3. Chin, N.-X. and Neu, H. C. (1984). Ciprofloxacin, a quinolone carboxylic add compound active against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 25, 319-26.
4. Easmon, C. S. F., Crane, J. P. and Blowers, A. (1986). Effect of riprofloxarin on intracellular organisms: in-vitro and in-vivo studies. Journal of Antimicrobial Chemotherapy 18, Suppl. D, 43-8.
5. Gargalianos, P., Jackson, P. T., Herzog, C. and Geddes, A. M. (1986). Trimethoprim in enteric fever. Journal of Antimicrobial Chemotherapy 18, 277-9.
6. Hajji, M., El Mdaghri, N., Benbachir, M., El Filali, K. M. and Himmich, H. (1988). Prospective randomized comparative trial of pefloxadn versus cotrimoxazole in the treatment of typhoid fever in adults. European Journal of Clinical Microbiology and Infectious Diseases 7, 361-3.
7. Herzog, C. and Geddes, A. M. (1982). Chloramphenicol in the treatment of enteric fever. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 848-9.
8. Limson, B. M. (1986). Efficacy and safety of dprofloxadn in uncomplicated typhoid fever. In First International Ciprofloxacin Workshop (Neu, H. C. and Weuta, H., Eds), pp. 362-4. Excerpta Medica, Amsterdam.
9. Ramirez, C. A., Bran, J. L., Mejia, C. R. and Garda, J. F. (1985). Open, prospective study of the dinical efficacy of dprofloxadn. Antimicrobial Agents and Chemotherapy 28, 128-32.
10. Sanford, S. P., Linh, N. N., Kutscher, E., Arnold, K. and Gould, K. (1976). Oxolinic add in the treatment of typhoid fever due to chloramphenicol resistant strains of Salmonella typhi. Antimicrobial Agents and Chemotherapy 9, 387-92.